Search Results - "Domingo, Walter"

Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen with Methotrexate-Based GvHD Prophylaxis by On, Sandy, Domingo, Walter, Cheung, Edna, Johnston, Laura

“…Introduction: Reduced-intensity conditioning (RIC) allogeneic stem cell transplant (allo-SCT) remains a curative option for elderly and/or unfit patients with…”
Get full text

Clofarabine and High-Dose Melphalan Reduced Intensity Conditioning Regimen for Allogeneic Stem Cell Transplantation by On, Sandy, Domingo, Walter, Cheung, Edna, Johnston, Laura

“…Fludarabine makes up the cornerstone of reduced-intensity conditioning (RIC) regimens for allogeneic stem cell transplant (alloHCT). However, during the…”
Get full text

The changing impact of cytomegalovirus among hematopoietic cell transplant recipients during the past decade: A single institutional cohort study by Johnsrud, Joyce J., Nguyen, Isabelle T., Domingo, Walter, Raval, Amit D., Tang, Yuexin, Narasimhan, Balasubramanian, Efron, Bradley, Brown, Janice (Wes)

“…Background With advancements in allogeneic hematopoietic cell transplantation (alloHCT), the need for cytomegalovirus (CMV) surveillance persists. Methods We…”
Get full text

Anakinra after Initial Tocilizumab Doses for Cytokine Release Syndrome (CRS) by Kim, Ailin Jennifer, Patel, Monank, Domingo, Walter, Frank, Matthew J., Latchford, Theresa M.

Get full text

199 - Anakinra after Initial Tocilizumab Doses for Cytokine Release Syndrome (CRS) by Kim, Ailin Jennifer, Patel, Monank, Domingo, Walter, Frank, Matthew J., Latchford, Theresa M.

Get full text

Effect of High Dose Valacyclovir Versus Standard Dose Acyclovir on HHV-6 after Umbilical Cord Blood Transplantation by Johnsrud, Joyce J., Domingo, Walter, Nguyen, Isabelle T., Brown, Janice (Wes)

Get full text

Continuous-Infusion Foscarnet Facilitates Administration in Hematopoietic Stem Cell Transplantation Patients by Domingo, Walter, Nguyen, Isabelle T., Johnsrud, Joyce J., Brown, Janice (Wes)

“…•Foscarnet is the most common therapy for patients who have resistant herpesvirus infections or intolerable cytopenias due to ganciclovir or…”
Get full text

Letermovir Prophylaxis Decreases Burden of Cytomegalovirus (CMV) in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant by Johnsrud, Joyce J., Nguyen, Isabelle T., Domingo, Walter, Narasimhan, Balasubramanian, Efron, Bradley, Brown, Janice (Wes)

“…Despite effective therapies, cytomegalovirus (CMV) continues to have a significant impact on morbidity and mortality in hematopoietic cell transplant…”
Get full text

Incidence and Impact of Cytomegalovirus in Hematopoietic Cell Transplant Recipients at a Single Center over the Last Decade by Johnsrud, Joyce J., Nguyen, Isabelle T., Domingo, Walter, Tang, Yuexin, Raval, Amit, Brown, Janice (Wes)

“…CMV continues to have a significant impact on HCT despite preemptive antiviral (PET) strategies. Our objective was to assess the incidence and impact of CMV in…”
Get full text

Letermovir Prophylaxis in Patients at High Risk for CMV Disease Following Hematopoietic Cell Transplant by Nguyen, Isabelle T., Johnsrud, Joyce J., Brown, Janice (Wes), Domingo, Walter

“…Starting January 2018 all adult HCT recipients at Stanford University who were at high risk (HR) for CMV disease received Letermovir prophylaxis (LET PPX). HR…”
Get full text